NCT07647770

Brief Summary

The goal of this clinical trial is to investigate the Impact of adding SIMV Synchronization to our standard PCV-VG mode of ventilation on muscle relaxant consumption, the frequency of relaxant top-ups and surgeon satisfaction during Laparoscopic Cholecystectomy surgeries in ASA I\&II. The main question it aims to answer is do Ventilator synchrony (PCV-VG+SIMV) reduces muscle relaxant consumption and improves surgeon satisfaction by minimizing the perception of inadequate paralysis? Primary hypothesis: Ventilator synchrony (PCV-VG+SIMV) reduces muscle relaxant consumption and improves surgeon satisfaction by minimizing the perception of inadequate paralysis. Primary outcome;

  1. 1.Compare total intraoperative rocuronium consumption (mg/kg) between PCV-VG and PCV-VG + SIMV
  2. 2.To determine the frequency of additional muscle relaxant requests

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
35mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 15, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2026

Expected
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2029

Last Updated

June 15, 2026

Status Verified

June 1, 2026

Enrollment Period

2.3 years

First QC Date

May 25, 2026

Last Update Submit

June 9, 2026

Conditions

Keywords

ventilator synchrony, muscle relaxant, laparoscopic cholecystectomy

Outcome Measures

Primary Outcomes (2)

  • Total intraoperative muscle relaxant consumption

    during the surgery time 1 to 2 hours

  • Number of surgeon request to rocuronium top-up doses

    during time of surgery from 1 to two hours

Secondary Outcomes (9)

  • Train of four (TOF) ratio

    during time of surgery from 1 to two hours

  • Peak airway pressure

    during time of surgery from 1 to two hours

  • Compliance

    during time of surgery from 1 to two hours

  • Delivered tidal volume

    during time of surgery from 1 to two hours

  • Surgeon satisfaction scores (Likert scale: 1-5)

    during time of surgery from 1 to two hours

  • +4 more secondary outcomes

Study Arms (2)

Non-Synchronized Group (Control)

ACTIVE COMPARATOR

Ventilation managed using PCV-VG mode of ventilation

Other: Non-Synchronized Group (Control)

Synchronized Group

ACTIVE COMPARATOR

Ventilation managed using PCV-VG plus SIMV (a mixed mode that supports patient-ventilator synchrony)

Other: Synchronized group

Interventions

Ventilation managed using PCV-VG mode of ventilation

Non-Synchronized Group (Control)

Ventilation managed using PCV-VG plus SIMV (a mixed mode that supports patient-ventilator synchrony)

Synchronized Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged 18-60 years undergoing elective laparoscopic cholecystectomy.
  • ASA (American Society of Anesthesiologists) physical status I-II
  • BMI 18-35 kg/m²

You may not qualify if:

  • Severe COPD or restrictive lung disease
  • Neuromuscular disorders
  • Emergency surgery
  • Morbid obesity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Fahd University Hospital

Khobar, Eastern Province, 34445, Saudi Arabia

Location

MeSH Terms

Conditions

Muscle Hypotonia

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Roshdi M Almetwalli, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Anesthesiologists will be divided into three groups; group one (the anesthesiologist who will perform anesthesia and respond to the surgical requests, group two (the anesthesiologist who will design the specific anesthetic plan, and ventilator sitting and the third group (the anesthesiologist who will collect the research data) both group one and three as well as the surgeon are blind to the study design and group assignment. The group two anesthesiologist will leave the room and will not attend the surgery.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Patients will be randomly allocated into two groups; Non-synchronized group which will be ventilated with pressure controlled volume guaranteed ventilation and Synchronized group which will be ventilated with pressure controlled volume guaranteed plus synchronized mode
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
consultant of anesthesia

Study Record Dates

First Submitted

May 25, 2026

First Posted

June 15, 2026

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

June 1, 2029

Last Updated

June 15, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

To protect patient privacy and confidentiality of data

Locations